Response Genetics Inc.Los Angeles, CA, United States (NASDAQ (CM): RGDX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Response Genetics Financial Statements

Response Genetics Financial Information

Company Type Public
Headquarters
Fiscal Year-End December

Response Genetics Income Statement

  2007 2006 2005
Revenue ($ mil.) 7.8 6.0 7.0
Gross Profit ($ mil.) 3.7 3.6 5.2
Operating Income ($ mil.) (5.5) (1.6) 1.9
Total Net Income ($ mil.) (5.1) (1.4) 1.9
Diluted EPS (Net Income) (0.78) (0.84) 0.31
More Response Genetics financial information

Response Genetics Stock Quote & Chart

10/14/08 09:32:53 EST • NASDAQ • 3.00 • Increased by +0.2700 • Increased by +9.8901 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Response Genetics Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 4.05 3.75 1.56
Price/Earnings Ratio -- 16.34 15.82
Price/Book Ratio 2.38 2.92 1.52
Price/Cash Flow Ratio -- 13.17 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Response Genetics Financial Ratios

Response Genetics Competitive Intelligence

Clinical Data Genomic Health Quest Diagnostics
Annual Sales ($ mil.) 63.7 64.0 6,704.9
Employees 459 288 43,500
Market Cap ($ mil.) -- 689.7 10,592.8

Competitive Landscape